Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bonkovsky

Showing results (41-50 of 401) with videos related to

Pageof 41
Sort By:
Seminars in Gastrointestinal Disease|June 18, 2002
Hemochromatosis and porphyriaRichard W Lambrecht, Herbert L Bonkovsky
The Journal of Clinical Ethics|January 1, 1996
Family dynamics and children in medical researchV M Gordon, F O Bonkovsky
Frontiers in Pharmacology|September 23, 2022
Eslicarbazepine acetate is porphyrogenic and should be used with caution in patients with the acute hepatic porphyriasChristopher D Ma, Herbert L Bonkovsky
Molecular Genetics and Metabolism Reports|September 15, 2022
Elagolix is porphyrogenic and may induce porphyric attacks in patients with the acute hepatic porphyriasChristopher D Ma, Herbert L Bonkovsky
Disease-A-Month : DM|January 1, 1989
The porphyriasJ R Bloomer, H L Bonkovsky
Clinics in Liver Disease|March 10, 2001
Iron-induced liver injuryH L Bonkovsky, R W Lambrecht
Clinics in Liver Disease|October 7, 2004
Hepatic porphyrias: diagnosis and managementAnnie T Chemmanur, Herbert L Bonkovsky
Gastroenterology|January 1, 1986
Fatal liver failure in protoporphyria. Synergism between ethanol excess and the genetic defectH L Bonkovsky, A R Schned
Seminars in Liver Disease|March 28, 1998
Diagnosis of porphyric syndromes: a practical approach in the era of molecular biologyH L Bonkovsky, G F Barnard
Clinical Liver Disease|April 18, 2019
Herbal and dietary supplement hepatotoxicityVinaya C Maddukuri, Herbert L Bonkovsky
Pageof 41

Showing results (41-50 of 401) with videos related to

Sort By:
Pageof 41
Seminars in Gastrointestinal Disease|June 18, 2002
Hemochromatosis and porphyriaRichard W Lambrecht, Herbert L Bonkovsky
The Journal of Clinical Ethics|January 1, 1996
Family dynamics and children in medical researchV M Gordon, F O Bonkovsky
Frontiers in Pharmacology|September 23, 2022
Eslicarbazepine acetate is porphyrogenic and should be used with caution in patients with the acute hepatic porphyriasChristopher D Ma, Herbert L Bonkovsky
Molecular Genetics and Metabolism Reports|September 15, 2022
Elagolix is porphyrogenic and may induce porphyric attacks in patients with the acute hepatic porphyriasChristopher D Ma, Herbert L Bonkovsky
Disease-A-Month : DM|January 1, 1989
The porphyriasJ R Bloomer, H L Bonkovsky
Clinics in Liver Disease|March 10, 2001
Iron-induced liver injuryH L Bonkovsky, R W Lambrecht
Clinics in Liver Disease|October 7, 2004
Hepatic porphyrias: diagnosis and managementAnnie T Chemmanur, Herbert L Bonkovsky
Gastroenterology|January 1, 1986
Fatal liver failure in protoporphyria. Synergism between ethanol excess and the genetic defectH L Bonkovsky, A R Schned
Seminars in Liver Disease|March 28, 1998
Diagnosis of porphyric syndromes: a practical approach in the era of molecular biologyH L Bonkovsky, G F Barnard
Clinical Liver Disease|April 18, 2019
Herbal and dietary supplement hepatotoxicityVinaya C Maddukuri, Herbert L Bonkovsky
Pageof 41